5'-OTBDMS-2'-OMe-G(iBu)
5'-OTBDMS-2'-OMe-G(iBu) - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.R2-149
-
SMILESO[C@H]1[C@@H](OC)[C@H](N(C=N2)C3=C2C(NC(NC(C(C)C)=O)=N3)=O)O[C@@H]1CO[Si](C)(C)C(C)(C)C
-
Molecular FormulaC21H35N5O6Si
-
Molecular Weight481.63
-
AppearanceReport result
-
PurityHPLC≥97%
-
Storage Condition2-8℃
Documentation
Documentation
-
Catalog No.R2-149
-
SMILESO[C@H]1[C@@H](OC)[C@H](N(C=N2)C3=C2C(NC(NC(C(C)C)=O)=N3)=O)O[C@@H]1CO[Si](C)(C)C(C)(C)C
-
Molecular FormulaC21H35N5O6Si
-
Molecular Weight481.63
-
AppearanceReport result
-
PurityHPLC≥97%
-
Storage Condition2-8℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
